Canada’s Cannabis Legalization Has Not Impacted Motor Vehicle and Pedestrian/Cyclist Injuries

A study published by the peer-reviewed journal Addiction has found that there “were no statistically significant changes in rates of emergency department visits and hospitalizations for motor vehicle or pedestrian/cyclist injury” following Canada legalizing marijuana.

Titled The effect of recreational cannabis legalization on rates of traffic injury in Canada, the study was published by researchers at St. Michael’s Hospital, the University of Toronto and the Toronto Centre for Addiction and Mental Health.

The aim of the study was to “measure the impact of Canada’s recreational cannabis legalization (RCL) in October 2018 and the subsequent impact of the COVID-19 lockdowns from March 2020 on rates of emergency department (ED) visits and hospitalizations for traffic injury.”

For the study an interrupted time series analysis of rates of ED visits and hospitalizations in Canada recorded in population-based databases from January/April 2010 to March 2021.

ED visits in Ontario and Alberta and hospitalizations in Ontario, Alberta, British Columbia, Prairies [Manitoba, Saskatchewan], and Maritimes [Nova Scotia, New Brunswick, Newfoundland, Prince Edward Island] were examined. Cases Monthly counts of presentations to the ED or hospital for motor vehicle injury or pedestrian/cyclist injury, used to calculate monthly rates per 100,000 population.

“An occurrence of one or more International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada (ICD-10-CA) code for motor vehicle injury (V20-V29, V40-V79, V30-39, V86) and pedestrian/cyclist injury (V01-V09, V10-V19) within the National Ambulatory Care Reporting System and Discharge Abstract Database” were used.

The study found that “There were no statistically significant changes in rates of ED visits and hospitalizations for motor vehicle or pedestrian/cyclist injury after RCL after accounting for multiple testing.”

Researchers note that “After COVID-19, there was an immediate decrease in the rate of ED visits for motor vehicle injury that was statistically significant only in Ontario (level change ß = -16.07 in Ontario, 95% confidence interval [CI] -20.55 to -11.60, p=0.000; ß = -10.34 in Alberta, 95% CI -17.80 to -2.89, p=0.008; alpha of 0.004) and no changes in rates of hospitalizations.”

The study concludes: “Canada’s recreational cannabis legalization (RCL) did not notably impact motor vehicle and pedestrian/cyclist injury. The rate of emergency department visits for motor vehicle injury decreased immediately after COVID-19, resulting in rates below post-RCL levels in the year after COVID-19.”

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders